MakeMyTrip Ltd. (MMYT) stock falls after being downgraded at Zacks Investment Research

Zacks Investment Research (MakeMyTrip Ltd.: NASDAQ) shares fell on Wednesday Dec 28 with lower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a downgraded rating.

Meanwhile, U.S. stocks were little changed on Wednesday, as investors found few reasons to keep pushing shares higher towards the 20,000 mark.

The Dow Jones Industrial Average DJIA, -0.11% rose 3.1 points to 19,949, essentially unchanged on the day. The S&P 500 SPX, -0.39% lost 3 points, or 0.1%, to 2,266 while the Nasdaq Composite Index COMP, -0.59% slipped 6.4 points, or 0.1%, to 5,482.

Analysts at Zacks Investment Research downgraded shares of Zacks Investment Research (MakeMyTrip Ltd.: NASDAQ) from Buy to Hold in a research note to investors today. Zacks Investment Research currently has a rating of Hold on the stock. The one-year price target of $26.81 is higher than the opening price of $23.85, that has caused a fair amount of other analysts to issue statements on the company in recent days. Looking back over the last 52 weeks, MakeMyTrip Ltd. stock has a high of $31.90. Downgrades occur when analysts believe that the future prospects for the security have weakened from the initial recommendation, often caused by an important and crucial digression in the company’s procedures, future vision or industry.

Shares of Zacks Investment Research (MakeMyTrip Ltd.: NASDAQ) opened at $23.85 on Tuesday and has traded in a range between, $23.20 and $24.00, and last traded at $23.25, which is a decrease of $0.65 per share or -2.72% from the previous closing price.

Zacks Investment Research (MakeMyTrip Ltd.: NASDAQ) currently has a market cap of 967.83M.

Zacks Investment Research (MakeMyTrip Ltd.: NASDAQ) Average Daily Trading Volume

The stock’s average daily volume is 570,065 shares out of a total float 30,245,000 and some 52,856 shares traded hands yesterday, lower than the norm. Investors often use upticks in trading volume to determine substantial volume aggregation or circulation by institutional investors, so trading volume is likely to increase in the next few days.

While increased trading for one day will not mean much, however, a trend of heavy trading volume on the buy side over a period of days or weeks expresses a positive indicator to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have teams of analysts that investigate thousands of stocks, so it is good corroboration to see them taking a postion in a stock you’re considering.

Zacks Investment Research (MakeMyTrip Ltd.: NASDAQ) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

Traders can make the best trades when they follow the trading habits of professional investors.

With that in mind, Zacks Investment Research (MakeMyTrip Ltd.: NASDAQ) now has a 50-day MA of $24.70 and 200-day MA of $21.17. It has traded in a 52-week range between $13.69 – 31.90 and today’s last price is 27.12%% lower than the 52 week high of $31.90.

Indeed, earnings growth is among the most important things to look at in regards to stock investing and, accordingly, investors seek companies that have been successful at growing their earnings at least 25% or more over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *